The primary difference between this and most of the stem cell therapies delivering mesechymal stem cells - which are more or less the standard type of cell to u

The primary difference between this and most of the stem cell therapies delivering mesechymal stem cells - which are more or less the standard type of cell to use for the moment, the most studied and most characterized, no-one got fired for using mesenchymal stem cells, etc - such as those widely available via medical tourism is the delivery to the brain. That isn't something clinics do, for all the obvious reasons. So I'm inclined to think that this is one of a number of different studies in recent years to demonstrate that the delivery methodology makes just as much of a difference as the type of cell lineage and any tinkering done to that cell lineage.